The deal

Recruitment specialist, SEC Life Sciences is set to enter a new phase of growth after our FRP Corporate Finance team secured a multimillion-pound refinancing package for the business.

SEC Life Sciences work with leading firms in the life sciences industry, from the earliest stages of product development right through to commercialisation providing solutions from Workforce Planning through to Retained Executive Search. Their deep roots in the fields of biotechnology, medical technology, digital health, medical devices, and pharmaceuticals have earned them a reputation for excellence in life science staffing, allowing them to swiftly match top candidates with the innovative companies that drive the sector forward.

With operations spanning the US, UK, DACH and mainland Europe they support life sciences firms in their pioneering work and support with the talent that brings their products to those who require them.

To support SEC Life Sciences growth ambitions, our Debt Advisory team, led by Partner Nick Grainger ran a tightly focussed process to deliver a hybrid debt facility to refinance the company. Simultaneously, our client finalised a shareholder restructuring, with management obtaining a majority stake.

Nick Grainger, Debt Advisory Partner at FRP Corporate Finance, said: “We’re delighted to have advised on this transaction. It sets the stage for SEC Life Sciences, guided by its highly experienced management team, to position the company for enhanced market presence and sustained success in the foreseeable future.”